A pilot study of magnetic seizure therapy for treatment‐resistant obsessive–compulsive disorder,Depression and Anxiety

当前位置： X-MOL 学术 › Depression Anxiety › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

A pilot study of magnetic seizure therapy for treatment‐resistant obsessive–compulsive disorder
Depression and Anxiety ( IF 7.4 ) Pub Date : 2020-09-19 , DOI: 10.1002/da.23097
Victor M Tang ₁ , Daniel M Blumberger _{1,

2} , Cory R Weissman ₁ , Julia Dimitrova _{1,

3} , Alanah Throop ₁ , Shawn M McClintock _{4,

5} , Daphne Voineskos ₁ , Tarek K Rajji _{1,

2} , Jonathan Downar _{2,

6} , Yuliya Knyahnytska ₁ , Benoit H Mulsant _{1,

2} , Paul B Fitzgerald ₇ , Zafiris J Daskalakis _{1,

2,

8}

Affiliation

There is growing interest in the potential of neuromodulation options in treatment‐resistant obsessive–compulsive disorder (OCD). Magnetic seizure therapy (MST), is a new treatment intervention in which generalized seizures are induced with transcranial magnetic stimulation. We conducted a pilot study to assess the efficacy and cognitive effects of MST in patients with treatment‐resistant OCD.

中文翻译：